Mumps and rubella consensus conference.
D000293:Adolescent; D000328:Adult; D002170:Canada / Q000453:epidemiology; D002423:Cause of Death; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008458:Measles Vaccine / Q000008:administration & dosage*; D022542:Measles-Mumps-Rubella Vaccine; D009107:Mumps / Q000401:mortality / Q000517:prevention & control*; D009108:Mumps Vaccine / Q000008:administration & dosage*; D011159:Population Surveillance; D011247:Pregnancy; D012409:Rubella / Q000401:mortality / Q000517:prevention & control*; D012410:Rubella Syndrome, Congenital / Q000401:mortality / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000008:administration & dosage*
D004338:Drug Combinations; D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine